FDA Goes Global: Trade Talks Suggest Drug Prices Are Part Of Mission
Executive Summary
FDA's involvement in trade negotiations with Australia is the latest sign that the agency's mission is evolving under Commissioner McClellan toward the once-taboo topic of pharmaceutical prices
You may also be interested in...
Drug R&D May Depend On Govt. Funds If Price Disparities Persist – Crawford
Drug price controls in the international market could lead to a reliance on government funds for pharmaceutical R&D, FDA Acting Commissioner Lester Crawford said
Drug R&D May Depend On Govt. Funds If Price Disparities Persist – Crawford
Drug price controls in the international market could lead to a reliance on government funds for pharmaceutical R&D, FDA Acting Commissioner Lester Crawford said
Genentech Rx For Global Pricing: Refuse To Sell Unless Price Is “Reasonable”
Pharmaceutical companies should not market products in countries that do not allow "reasonable" prices for drugs, Genentech CEO Arthur Levinson declared during a March 12 investor conference